Article: Bilberry extract's cancer fighting capability put to the test

Report from the Asian News International brought to you by the Hindustan Times

Washington, Oct. 5 -- Researchers at the University of Leicester are investigating whether an extract from bilberries Mirtoselect can put off or delay the onset of certain cancers.

A team of researchers led by Professor Andy Gescher is working on a study to carry out clinical trials with the commercially produced substance Mirtoselect, involving patients about to undergo surgery for colorectal and liver cancer.

The research project has already shown in a laboratory model that Mirtoselect decreases the development of colorectal cancer.

Now, they are looking to see how much of the bilberry extract actually gets ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!